178 related articles for article (PubMed ID: 32064177)
1. Pre-diagnosis Multidisciplinary Tumor Board and Time to Staging in Lung Cancer: The Case Western MetroHealth Experience.
Thalanayar Muthukrishnan P; Ratnam M; Nguyen MT; Le M; Gunzler D; Bruno D; Infeld M
Cureus; 2020 Jan; 12(1):e6595. PubMed ID: 32064177
[TBL] [Abstract][Full Text] [Related]
2. Thoracic multidisciplinary tumor board routinely impacts therapeutic plans in patients with lung and esophageal cancer: a prospective cohort study.
Schmidt HM; Roberts JM; Bodnar AM; Kunz S; Kirtland SH; Koehler RP; Hubka M; Low DE
Ann Thorac Surg; 2015 May; 99(5):1719-24. PubMed ID: 25678503
[TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary Cancer Management of Colorectal Cancer in Tikur Anbessa Specialized Hospital, Ethiopia.
Deressa BT; Cihoric N; Tefesse E; Assefa M; Zemenfes D
J Glob Oncol; 2019 Oct; 5():1-7. PubMed ID: 31589543
[TBL] [Abstract][Full Text] [Related]
4. Validation of team performance assessment of multidisciplinary tumor boards.
Jalil R; Akhter W; Lamb BW; Taylor C; Harris J; Green JS; Sevdalis N
J Urol; 2014 Sep; 192(3):891-8. PubMed ID: 24631109
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study.
Tamburini N; Maniscalco P; Mazzara S; Maietti E; Santini A; Calia N; Stefanelli A; Frassoldati A; Santi I; Rinaldi R; Nigim F; Righi R; Pedrazzi S; Cavallesco G
Eur J Cardiothorac Surg; 2018 Jun; 53(6):1199-1204. PubMed ID: 29293943
[TBL] [Abstract][Full Text] [Related]
6. Contribution of FDG-PET/CT to the management of esophageal cancer patients at multidisciplinary tumor board conferences.
Shashi KK; Madan R; Hammer MM; van Hedent S; Byrne SC; Schmidlin EJ; Mamon H; Hatabu H; Enzinger PC; Gerbaudo VH
Eur J Radiol Open; 2020; 7():100291. PubMed ID: 33304940
[TBL] [Abstract][Full Text] [Related]
7. Do Multidisciplinary Tumor Board Discussions Correlate With Increase in 5-Year Survival? A Meta-Analysis Study.
Algwaiz G; Salam Y; Bustami R; Ferwana M; Jazieh AR
Glob J Qual Saf Healthc; 2021 Feb; 4(1):3-10. PubMed ID: 37260532
[TBL] [Abstract][Full Text] [Related]
8. Improving coordination of lung cancer care at a tertiary healthcare center in Saudi Arabia.
Alkhathlan A; Alfaiz R; Almusallam G; Arabi E; Alkaiyat M; Jazieh A
Saudi Med J; 2022 Mar; 43(3):313-316. PubMed ID: 35256500
[TBL] [Abstract][Full Text] [Related]
9. Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center.
Jain NM; Schmalz L; Cann C; Holland A; Osterman T; Lang K; Wiesner GL; Pal T; Lovly C; Stricker T; Micheel C; Balko JM; Johnson DB; Park BH; Iams W
Oncologist; 2021 Nov; 26(11):e1962-e1970. PubMed ID: 34390291
[TBL] [Abstract][Full Text] [Related]
10. Physician compliance with multidisciplinary tumor board recommendations for managing gynecological cancers.
Naessens C; Laloze J; Leobon S; Gauthier T; Lacorre A; Monteil J; Venat L; Deluche E
Future Oncol; 2023 Apr; 19(13):897-908. PubMed ID: 37232140
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting.
VanderWalde A; Grothey A; Vaena D; Vidal G; ElNaggar A; Bufalino G; Schwartzberg L
J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33260805
[TBL] [Abstract][Full Text] [Related]
12. Molecular Tumor Board Review and Improved Overall Survival in Non-Small-Cell Lung Cancer.
Huang B; Chen Q; Allison D; El Khouli R; Peh KH; Mobley J; Anderson A; Durbin EB; Goodin D; Villano JL; Miller RW; Arnold SM; Kolesar JM
JCO Precis Oncol; 2021; 5():. PubMed ID: 34622117
[TBL] [Abstract][Full Text] [Related]
13. Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study.
Stone E; Rankin N; Kerr S; Fong K; Currow DC; Phillips J; Connon T; Zhang L; Shaw T
Lung Cancer; 2018 Oct; 124():199-204. PubMed ID: 30268461
[TBL] [Abstract][Full Text] [Related]
14. Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.
Koopman B; Groen HJM; Ligtenberg MJL; Grünberg K; Monkhorst K; de Langen AJ; Boelens MC; Paats MS; von der Thüsen JH; Dinjens WNM; Solleveld N; van Wezel T; Gelderblom H; Hendriks LE; Speel EM; Theunissen TE; Kroeze LI; Mehra N; Piet B; van der Wekken AJ; Ter Elst A; Timens W; Willems SM; Meijers RWJ; de Leng WWJ; van Lindert ASR; Radonic T; Hashemi SMS; Heideman DAM; Schuuring E; van Kempen LC
Oncologist; 2021 Aug; 26(8):e1347-e1358. PubMed ID: 33111480
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.
Tafe LJ; Gorlov IP; de Abreu FB; Lefferts JA; Liu X; Pettus JR; Marotti JD; Bloch KJ; Memoli VA; Suriawinata AA; Dragnev KH; Fadul CE; Schwartz GN; Morgan CR; Holderness BM; Peterson JD; Tsongalis GJ; Miller TW; Chamberlin MD
Oncologist; 2015 Sep; 20(9):1011-8. PubMed ID: 26205736
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the impact of the genitourinary multidisciplinary tumour board: Should every cancer patient be discussed as standard of care?
Scarberry K; Ponsky L; Cherullo E; Larchian W; Bodner D; Cooney M; Ellis R; Maclennan G; Johnson B; Tabayoyong W; Abouassaly R
Can Urol Assoc J; 2018 Sep; 12(9):E403-E408. PubMed ID: 29787374
[TBL] [Abstract][Full Text] [Related]
17. Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor Board.
Michaelis J; Himmelsbach R; Metzger P; Lassmann S; Börries M; Werner M; Miething C; Höfflin R; Illert AL; Duyster J; Becker H; Sigle A; Gratzke C; Grabbert M
Urol Int; 2024 Apr; ():1-9. PubMed ID: 38626735
[TBL] [Abstract][Full Text] [Related]
18. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
19. Image analysis in posttreatment non-small cell lung cancer surveillance: specialists' interpretations reviewed by the thoracic multidisciplinary tumor board.
Gambazzi F; Frey LD; Bruehlmeier M; Janthur WD; Heuberger J; Spirig A; Williams R; Zweifel R; Boerner B; Tini GM; Irani S
Multidiscip Respir Med; 2019; 14():34. PubMed ID: 31827794
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
